Nuvectis Pharma, Inc.NVCT
What Nuvectis Pharma, Inc. does.
We are a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. We seek to develop drug candidates in the precision medicine space, and our processes for selection and clinical development of drug candidates are based on scientific data into cancer-promoting factors, as well as our understanding of the clinical landscape and regulatory requirements.
We were incorporated in July 2020 under the laws of the State of Delaware under the name Centry Pharma, Inc., and changed our name to Nuvectis Pharma, Inc. in July 2021. Our office is located at 1 Bridge Plaza, 2 nd Floor, Fort Lee, NJ 07024, and our telephone number is (201) 614-3150.
We maintain a website with the address www.nuvectis.com. We make available free of charge through our website our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and any amendments to these reports, as soon as reasonably practicable after we electronically file such material with, or furnish such material to, the Securities and Exchange Commission (“SEC”). We are not including the information on our website as a part of, nor incorporating it by reference into, this report. Additionally, the SEC maintains a website that contains annual, quarterly, and current reports, proxy statements, and other information that issuers (including us) file electronically with the SEC. The SEC’s website address is http://www.sec.gov.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | — | -$12.9M | -$19.1M | -$22.3M | -$19.0M | -$26.4M |
More on NVCT.
- Nuvectis Pharma, Inc. summary
- Nuvectis Pharma, Inc. financial statements
- Nuvectis Pharma, Inc. key metrics
- Nuvectis Pharma, Inc. health scores and style box
- Nuvectis Pharma, Inc. earnings
- Nuvectis Pharma, Inc. dividends
- Nuvectis Pharma, Inc. valuation
- Nuvectis Pharma, Inc. ownership and insiders
- Nuvectis Pharma, Inc. peers
Figures from Nuvectis Pharma, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.